MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE FLEX W/SHIELD TECHNOLOGY; INTRACRANIAL ANEURYSM FLOW DIVERTER
|
Back to Search Results |
|
Model Number PED2-500-20 |
Device Problem
Activation Failure (3270)
|
Patient Problems
No Known Impact Or Consequence To Patient (2692); No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 09/21/2020 |
Event Type
malfunction
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received a report that the distal end of the pipeline opened, but then dog boned in the middle section while the rest of the device continued to open.An attempt was made to recapture and reopen was performed once, but with no success.It was noted the device was not positioned in a bend, more than 50% of the device had been deployed when it failed to open, and no additional steps were taken to open the device.The procedure was completed with no issues by using another pipeline device.It was indicated that all devices were prepared as per the instructions for use (ifu), and no patient symptoms or further complications were reported as a result of this event.The patient was undergoing surgery for treatment of asaccular, unruptured aneurysm of the paraopthalmic internal carotid artery.It was noted the patient's vessel tortuosity was moderate.Dual antiplatelet therapy (dapt) was administered, and the platelet reactivity units (pru) level was unknown.Ancillary devices include a fubuki 8f, via 27, synchro 14.
|
|
Manufacturer Narrative
|
The pipeline flex embolization device was returned for analysis within a shipping box; within a sealed pouch; within an opened pipeline flex inner pouch (b019200) and within a (microvention) via 27 catheter.The pipeline flex pusher was found protruding from within the via 27 catheter hub for ~41.8cm.No apparent damages were found with the via 27 catheter.The pipeline flex tip coil was found protruding from within the via 27 catheter distal tip.The pipeline flex pusher was able to be pulled out from within the via 27 catheter without issue.The pipeline flex distal hypotube and ptfe shrink tubing were found intact.The pipeline flex pusher was found detached at the distal hypotube weld (solder joint).The via 27 catheter was dissected (cut) and the pipeline flex detached distal segment was removed.The resheathing pad/marker were found in good condition.The pipeline flex braid ends were found fully open.The pipeline flex braid distal end was found damaged (frayed).The pipeline flex distal wire was found separated proximal to the ptfe sleeves.The ptfe sleeves were found to be in good condition.The detached/broken ends of the pusher were sent out for sem (scanning electron micrographic) / eds (energy dispersive spectroscopy) analysis.No other anomalies were observed.Based on the device analysis and reported information, the customer¿s report of ¿failure/incomplete open¿ could not be confirmed, as the device has been fully deployed and re-sheathed.Possible causes for failure to open are patient vessel tortuosity, damaged braid, braid improperly sized to an atomy, braid was overstretched during delivery, user deploys braid in vessel bend, presence of other indwelling endovascular stents, or inappropriate anatomy.However, the cause for the failure to open could not be determined.Regarding the solder joint separation issue, separation can occur due to excessive force or inadequate solder/tinning.As the analysis showed presence of soldering material (tin); thereby indicating that the soldering was conducted.A review of the manufacturing process did not uncover any deficiencies with regard to the soldering process.Proper soldering technique and surface preparation (tinning) were well defined and documented appropriately in the associated manufacturing procedures.The proof load of 2.5n performed on 100% of the devices (section starting with hypotube solder to distal pad solder joint).T here was no non-conformance to specification that lead to the resistance and detachment issues.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|